Intelligent Bio Solutions Research and Development Expenses 2020-2024 | INBS

Intelligent Bio Solutions research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Intelligent Bio Solutions Research and Development Expenses 2020-2024 | INBS

Intelligent Bio Solutions research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$121.5B
Cencora (COR)$44.3B
ICON (ICLR)$23.6B
DiDi Global (DIDIY)$23.3B
Avantor (AVTR)$17.6B
Natera (NTRA)$15.5B
Revvity (RVTY)$15.5B
Viatris (VTRS)$13.8B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$11.7B
Medpace Holdings (MEDP)$10.3B
Charles River Laboratories (CRL)$10.2B
Sonic Healthcare (SKHHY)$9.1B
Doximity (DOCS)$8B
HealthEquity (HQY)$7B
Bausch + Lomb (BLCO)$6.7B
PACS (PACS)$6B
Organon (OGN)$4.9B
Life Times (LTH)$4.8B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4.1B
Concentras Parent (CON)$2.8B
Ardent Health Partners (ARDT)$2.6B
GoodRx Holdings (GDRX)$2.6B
BrightSpring Health Services (BTSG)$2.6B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.6B
CareDx (CDNA)$1.6B